J
Jean-Christophe Lagier
Researcher at Aix-Marseille University
Publications - 311
Citations - 17625
Jean-Christophe Lagier is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Genome & Medicine. The author has an hindex of 50, co-authored 274 publications receiving 13861 citations. Previous affiliations of Jean-Christophe Lagier include Institut de recherche pour le développement & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Evaluation of pain susceptibility by taking blood pressure in patients with infections: A prospective comparative study.
Carole Eldin,Sophia Boudjema,Line Meddeb,Laurent Boyer,Christophe Soriano,Philippe Parola,Jean-Christophe Lagier,Andreas Stein,Frédérique Gouriet,Philippe Gautret,Matthieu Million,Didier Raoult +11 more
TL;DR: In this article, the blood pressure cuff-evoked pain threshold (BPCEPT) was used as a screening test for detecting pain sensitization in patients suffering from infectious diseases and the positive control group had significantly lower values of the BPCEPT than all other groups.
Journal ArticleDOI
Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening
Amar Bouam,Jean-Jacques Vincent,Elisabeth Le Glass,Lionel Almeras,Pierre-Yves Levy,Hervé Tissot-Dupont,Jean-Christophe Lagier,Pierre-Edward Fournier,Didier Raoult,Michel Drancourt +9 more
TL;DR: A commercially available isothermal amplification of SARS-CoV-2 RNA was applied to self-collected saliva samples using dry dental cotton rolls, which were held in the mouth for two minutes.
Journal ArticleDOI
Maliibacterium massiliense gen. nov. sp. nov., Isolated from Human Feces and Proposal of Maliibacteriaceae fam. nov.
Sory Ibrahima Traore,Cheikh Ibrahima Lo,Guillaume André Durand,Jean-Christophe Lagier,Didier Raoult,Pierre-Edouard Fournier,Florence Fenollar +6 more
Journal ArticleDOI
Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
Matthieu Million,Jean-Christophe Lagier,Jérôme Hourdain,Frédéric Franceschi,Jean-Claude Deharo,Philippe Parola,Philippe Brouqui +6 more
TL;DR: In this article , the authors report a pragmatic and simple safety approach which was implemented among the first patients treated for COVID-19 in early 2020 in a center in early 2019, and show that a simple initial assessment of patient medical history, electrocardiogram (ECG), and kalemia identifies contraindicated patients and enables the safe treatment of COVID19 patients with HCQ-AZ.
Journal ArticleDOI
Campylobacter jejuni infection associated with miscarriage, a case report and literature review.
TL;DR: Clinicians should consider this cause of miscarriage in febrile pregnant women, as the bacterium is resistant to many beta-lactam antibiotics, and macrolides are the first-line treatment.